← 產業報告目錄

Medical Polymer Market by Type (Medical Plastics, Medical Elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Chemicals & Materials出版日期 2025-09-05頁數 451報告編號 CH9017

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The medical polymer market is projected to reach USD 66.29 billion by 2030 from USD 44.70 billion in 2025, at a CAGR of 8.2% during the forecast period. The medical polymer market is experiencing rapid growth as a result of continual progress in healthcare, materials engineering, and patient-focused innovation. Major factors driving include need for materials that are lightweight, durable, and suitable for use in situations involving biocompatible materials, like implants or catheters, diagnostic equipment, and even surgical instruments. The increased prevalence of chronic diseases, aging population, and the need for minimally invasive procedures is creating preference for advanced polymers that provide flexibility, security, and accuracy. The considerable shift in the use of disposable medical products, where possible, for sanitation and fewer contaminants has contributed to the proliferation of components made from polymers. The science of polymers is advancing to create polymers and materials with superior mechanical strength, durability, antimicrobial properties, and compatibility with active-sterilization techniques. Advances in knowledge and developments have resulted in breakthroughs in polymers that can hold shapes, or bioresorbable, that offer opportunities in the areas of drug delivery devices and tissue engineering. Proliferation of medical-grade 3D printing has revolutionized this area because custom-designed implants and devices can now be developed rapidly. There has increased attention on sustainable practices, leading to interest in recyclable and biodegradable polymers. “Medical elastomers to account for the second-largest type in the medical polymer market during the forecast period.” Medical elastomers account for the second-largest type in the medical polymer market based on unique combinations of characteristics, such as flexibility, durability, and biocompatibility, allowing them to be used for hundreds of precise applications for critical healthcare. Many of the devoted elastomer applications are products used to contain fluids or products that need to be manipulated with constant movement, stretching, or compression, like seals, gaskets, tubing, syringes, plungers, and catheter components. Medical elastomer products are best known because of their chemical resistance, resistance to temperature swings, and resistance to sterilization techniques, which enables reliable products in high-stress medical applications. Because silicone elastomers, thermoplastic elastomers (TPE), and rubber materials are often specifically mentioned in literature due to increased comfort above conventional or hard polymers, they are favored for wearable medical devices and skin-contact applications. In addition, the influence of minimization continues to drive performance elastomeric materials, as do the advanced design aspects influencing drug delivery systems, automated enclosed testing systems, and lifestyle diagnostic devices. Furthermore, elastomeric materials are especially amenable to automated manufacturing and/or molding with E-modulus and tensile strength decreases, enabling cost-effective production in considerably large amounts. Combined with supporting and allowing innovation and safety in modern healthcare, these ultimately contribute to the fast-growing and extremely important category of medical elastomers in the medical polymer market. “Medical disposables to account for the second-largest share of the medical polymer market during the forecast period.” Medical disposables are the second-largest application in the medical polymer market because of their importance in cleanliness, patient safety, and infection control in healthcare settings. Items such as syringes, gloves, IV bags, tubing and connections, surgical drapes, and masks are designed for single-use to prevent cross-contamination and maintain sterile environments. The emphasis on infection prevention and regulations supporting infection control have increased demand for disposable medical items. Due to their excellent processability, low cost, and compatibility with sterilizing processes, the polymers used in medical disposables are primarily polypropylene, polyethylene, and PVC. The increase in hospital stays, enhanced surgical procedures, and outpatient care, especially in emerging regions, are driving demand for good quality disposables. Convenience of ready-to-use pre-sterilized items can add efficiency in busy medical settings. As healthcare continues to focus on safety, cost-effective practices, and efficiencies, polymer medical disposables will be an important future growth area going forward. “Injection molding is projected to be the second-largest manufacturing technology in the medical polymer market during the forecast period.” Injection molding is the second-largest manufacturing technology in the medical polymer space because it can produce highly precise and complex components at scale with good reliability and efficiency. Injection molding is used to produce a wide variety of medical products, for example, housing for diagnostic equipment, surgical instrument handles, syringes, connectors, components of implantable devices, and so forth. Injection molding is compatible with many medical-grade polymers, for example, it can be made from polycarbonate, polypropylene, and ABS. With injection molding, the manufacture of components that must have strength, biocompatibility, chemical resistance, and washability is possible. Injection molding can be made to tight tolerances with complex geometries; all of which are relevant in meeting the safety and performance requirements of the medical device industry. Injection molding is also compatible with automation and is conducive to produce items in large volumes while being cost-effective along with high quality output. Recent advancements in multi-shot and micro fabrication further enhances the application range as well. With all of these advantages it is easy to see how injection molding plays a critical role in the medical polymer market which supports product innovations and continues to aid the demand for sophisticated and reliable medical products. “North America is projected to be the second-fastest growing region in the medical polymer market during the forecast period.” North America is the second-fastest growing region in the medical polymer market, due largely to strong healthcare dynamics, and innovated demand. Per capita healthcare expenses are rising, initiated by expanding insurance coverage in the US and strong public and private healthcare investments in Canada. The medical devices, packaging, and wound care categories are projected to account for greater growth in North America than any other region as healthcare advances. However, the US has one of the most innovative healthcare environments in the world based on a developed healthcare infrastructure, a strong Research and Development (R&D) ecosystem, and a strong partnership with the polymer industry, leading to the creation of a broad and expanding array of high-performance polymers. Many of these polymers have properties that are biocompatible and even biodegradable (resins and fibers) for surgical devices, diagnostics, and drug delivery systems. The healthcare industry relies on new product designs and innovative ideas regarding the use of new products developments (e.g., PEEK and other engineering plastics), to ensure successful product introduction that will also meet patients' preferences for disposable, minimally invasive, and home care solutions. While the Asia Pacific region is leading with the highest CAGR, North America is the second-fastest growing region, due to its regulatory strength (and US regulation innovation), established healthcare system, and leading region with polymer manufacturers serving patients and the medical sector without sacrificing innovation in the development of polymer technologies. Extensive interviews with experts were conducted to determine and verify the market size for several segments and subsegments and the information gathered through secondary research. The break-up of interviews with experts is given below: • By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35% • By Designation: C Level: 35%, Director Level: 30%, and Executives: 35% • By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5% BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others are some of the key players in the medical polymer market. The study includes an in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies. Research Coverage The market study covers the medical polymer market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on type, application, manufacturing technology, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to enhance their positions in the medical polymer market. Key Benefits of Buying the Report The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical polymer market and its segments and subsegments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the positions of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), challenges (Cost constraints for novel materials, Long term durability and degradation control) • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the medical polymer market • Market Development: Comprehensive information about lucrative markets – the report analyzes the medical polymer market across varied regions • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical polymer market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others are covered in the medical polymer market.
目錄 Table of Contents
1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE 28 1.3.1 INCLUSIONS AND EXCLUSIONS 29 1.3.2 YEARS CONSIDERED 29 1.4 CURRENCY CONSIDERED 29 1.5 UNITS CONSIDERED 30 1.6 STAKEHOLDERS 30 1.7 SUMMARY OF CHANGES 30 2 RESEARCH METHODOLOGY 31 2.1 RESEARCH DATA 31 2.1.1 SECONDARY DATA 32 2.1.1.1 List of major secondary sources 32 2.1.1.2 Key data from secondary sources 32 2.1.2 PRIMARY DATA 33 2.1.2.1 Key data from primary sources 33 2.1.2.2 List of primary interview participants—demand and supply side 34 2.1.2.3 Key industry insights 34 2.1.2.4 Breakdown of primary interviews 34 2.2 MARKET SIZE ESTIMATION 35 2.2.1 BOTTOM-UP APPROACH 35 2.2.2 TOP-DOWN APPROACH 36 2.3 FORECAST NUMBER CALCULATION 37 2.4 DATA TRIANGULATION 37 2.5 FACTOR ANALYSIS 38 2.6 RESEARCH ASSUMPTIONS 39 2.7 LIMITATIONS AND RISKS 39 3 EXECUTIVE SUMMARY 41 4 PREMIUM INSIGHTS 45 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET 45 4.2 MEDICAL POLYMER MARKET, BY TYPE 45 4.3 MEDICAL POLYMER MARKET, BY APPLICATION 46 4.4 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 46 4.5 MEDICAL POLYMER MARKET, BY COUNTRY 47 5 MARKET OVERVIEW 48 5.1 INTRODUCTION 48 5.2 MARKET DYNAMICS 48 5.2.1 DRIVERS 49 5.2.1.1 Increasing demand for biocompatible materials 49 5.2.1.2 Surge in global aging population 49 5.2.1.3 Advancements in medical technology 50 5.2.1.4 Rise in chronic diseases 50 5.2.1.5 Regulatory support for medical-grade materials 50 5.2.2 RESTRAINTS 51 5.2.2.1 Regulatory complexities and approvals 51 5.2.2.2 High competition from alternative materials 51 5.2.2.3 Environmental sustainability concerns 52 5.2.3 OPPORTUNITIES 52 5.2.3.1 Growth in regenerative medicine 52 5.2.3.2 Demand for minimally invasive devices 53 5.2.3.3 Advancements in biodegradable polymers 53 5.2.4 CHALLENGES 54 5.2.4.1 Cost constraints for novel materials 54 5.2.4.2 Long-term durability and degradation control 55 5.3 PORTER’S FIVE FORCES ANALYSIS 55 5.3.1 THREAT FROM NEW ENTRANTS 56 5.3.2 THREAT OF SUBSTITUTES 57 5.3.3 BARGAINING POWER OF BUYERS 57 5.3.4 BARGAINING POWER OF SUPPLIERS 57 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 58 5.4 MACROECONOMIC INDICATORS 58 5.4.1 GLOBAL GDP TRENDS 58 6 INDUSTRY TRENDS 60 6.1 INTRODUCTION 60 6.2 KEY STAKEHOLDERS & BUYING CRITERIA 60 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 60 6.2.2 BUYING CRITERIA 61 6.3 VALUE CHAIN ANALYSIS 62 6.3.1 RAW MATERIAL SUPPLIERS 63 6.3.2 MANUFACTURERS 64 6.3.3 DISTRIBUTORS 64 6.3.4 END CONSUMERS 64 6.4 ECOSYSTEM ANALYSIS 64 6.5 CASE STUDY ANALYSIS 65 6.5.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS 65 6.5.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY 66 6.6 REGULATORY LANDSCAPE 66 6.7 TECHNOLOGY ANALYSIS 69 6.7.1 KEY TECHNOLOGY 69 6.7.1.1 Biocompatible polymers 69 6.7.1.2 Thermoplastic elastomers 69 6.7.2 COMPLEMENTARY TECHNOLOGY 70 6.7.2.1 Thermoplastic elastomers 70 6.7.2.2 Surface modification techniques 70 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 70 6.9 TRADE ANALYSIS 71 6.9.1 IMPORT SCENARIO 71 6.9.2 EXPORT SCENARIO 73 6.10 KEY CONFERENCES & EVENTS, 2025−2026 74 6.11 PRICING ANALYSIS 75 6.11.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 75 6.11.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022–2024 76 6.11.3 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 76 6.12 INVESTMENT AND FUNDING SCENARIO 78 6.13 PATENT ANALYSIS 78 6.13.1 METHODOLOGY 78 6.13.2 PATENTS GRANTED WORLDWIDE, 2015–2024 79 6.13.3 PUBLICATION TRENDS 79 6.13.4 INSIGHTS 80 6.13.5 LEGAL STATUS OF PATENTS 80 6.13.6 JURISDICTION ANALYSIS 80 6.13.7 TOP APPLICANTS 81 6.14 IMPACT OF AI/GEN AI ON MEDICAL POLYMER MARKET 82 6.15 IMPACT OF 2025 US TARIFF ON MEDICAL POLYMER MARKET 83 6.15.1 INTRODUCTION 83 6.15.2 KEY TARIFF RATES 83 6.15.3 PRICE IMPACT ANALYSIS 84 6.15.4 IMPACT ON KEY COUNTRIES/REGIONS 84 6.15.4.1 North America 84 6.15.4.2 Europe 85 6.15.4.3 Asia Pacific 85 6.15.5 IMPACT ON END-USE INDUSTRIES 85   7 MEDICAL POLYMER MARKET, BY TYPE 86 7.1 INTRODUCTION 87 7.2 MEDICAL PLASTICS 92 7.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET 92 7.2.2 POLYPROPYLENE 92 7.2.3 POLYVINYL CHLORIDE 92 7.2.4 POLYETHYLENE 92 7.2.5 POLYSTYRENE 93 7.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS 93 7.2.6.1 Polyether ether ketone 93 7.2.6.2 Nylon/polyamide 93 7.2.6.3 Polyphenylsulfone 94 7.2.6.4 Polysulfones 94 7.2.6.5 Polymethyl methacrylate 94 7.2.6.6 Polycarbonate 94 7.2.6.7 Acrylonitrile butadiene styrene 94 7.2.6.8 Other Engineering & high-performance plastics 95 7.2.7 OTHER MEDICAL PLASTICS 95 7.3 MEDICAL ELASTOMERS 95 7.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET 95 7.3.2 SILICONE 95 7.3.3 THERMOPLASTIC ELASTOMERS 96 7.3.3.1 Thermoplastic polyurethane 96 7.3.3.2 Thermoplastic vulcanizates 96 7.3.3.3 Thermoplastic styrenic elastomers 96 7.3.3.3.1 Poly(styrene-butadiene-styrene) 97 7.3.3.3.2 Styrene-ethylene-butylene-styrene 97 7.3.3.4 Thermoplastic copolyester elastomers 97 7.4 OTHER MEDICAL ELASTOMERS 97 8 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 98 8.1 INTRODUCTION 99 8.2 EXTRUSION TUBING 101 8.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET 101 8.3 COMPRESSION MOLDING 101 8.3.1 INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET 101 8.4 INJECTION MOLDING 101 8.4.1 INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET 101 8.5 OTHER MANUFACTURING TECHNOLOGIES 102 9 MEDICAL POLYMER MARKET, BY APPLICATION 103 9.1 INTRODUCTION 104 9.2 MEDICAL DISPOSABLES 109 9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET 109 9.2.2 GLOVES 109 9.2.3 SYRINGES 109 9.2.4 MEDICAL BAGS 110 9.2.5 OTHER MEDICAL DISPOSABLES 110 9.3 MEDICAL INSTRUMENTS & DEVICES 111 9.3.1 INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET 111 9.3.2 MEDICAL TUBES 111 9.3.3 CATHETERS 111 9.3.4 DRUG DELIVERY INSTRUMENTS 112 9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES 112 9.4 PROSTHETICS 113 9.4.1 RISING DEMAND FOR ADVANCED LIMB PROSTHESES AND IMPLANTS TO DRIVE MARKET 113 9.4.2 IMPLANTS 113 9.4.3 LIMB PROSTHESIS 113 9.4.4 OTHER PROSTHETICS APPLICATIONS 114 9.5 DIAGNOSTIC INSTRUMENTS & TOOLS 114 9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET 114 9.5.2 DENTAL TOOLS 114 9.5.3 SURGICAL INSTRUMENTS 115 9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS 115 9.6 OTHER APPLICATIONS 116 10 MEDICAL POLYMER MARKET, BY REGION 117 10.1 INTRODUCTION 118 10.2 NORTH AMERICA 120 10.2.1 US 131 10.2.1.1 High R&D investments in medical sector to drive market 131 10.2.2 CANADA 139 10.2.2.1 Emerging demand for dental implants to drive market 139 10.2.3 MEXICO 148 10.2.3.1 Expansion of manufacturing facilities to drive market 148 10.3 ASIA PACIFIC 156 10.3.1 CHINA 168 10.3.1.1 Establishment of medical device manufacturing units and investment in other healthcare-related sectors to drive market 168 10.3.2 INDIA 176 10.3.2.1 Rapid economic growth and growing population to drive market 176 10.3.3 SOUTH KOREA 185 10.3.3.1 Advanced healthcare and medical technologies to boost market 185 10.3.4 JAPAN 193 10.3.4.1 Developments in minimally invasive treatment and robotic surgery to support market growth 193 10.3.5 AUSTRALIA 201 10.3.5.1 Regulatory compliance and strategic collaborations to support market growth 201 10.3.6 REST OF ASIA PACIFIC 209 10.4 MIDDLE EAST & AFRICA 217 10.4.1 GCC COUNTRIES 228 10.4.1.1 Saudi Arabia 229 10.4.1.1.1 Surge in aging population to drive demand for medical polymers 229 10.4.1.2 UAE 237 10.4.1.2.1 Population growth and changing epidemiology to drive market 237 10.4.1.3 Rest of GCC 245 10.4.2 SOUTH AFRICA 253 10.4.2.1 Increased government spending on healthcare to drive market 253 10.4.3 REST OF MIDDLE EAST & AFRICA 261 10.5 EUROPE 270 10.5.1 GERMANY 281 10.5.1.1 Rising demand in dental implant application to drive market 281 10.5.2 FRANCE 289 10.5.2.1 Aging population and sedentary lifestyle to boost demand for polymers 289 10.5.3 UK 297 10.5.3.1 Growing incidences of chronic diseases and government support for innovation to drive market 297 10.5.4 ITALY 305 10.5.4.1 Strong production facilities with presence of global players to propel market growth 305 10.5.5 SPAIN 313 10.5.5.1 Surge in government funding for healthcare sector to support market 313 10.5.6 REST OF EUROPE 321 10.6 SOUTH AMERICA 329 10.6.1 BRAZIL 340 10.6.1.1 Growing aging population, expanding economy, and increasing health awareness to drive market 340 10.6.2 ARGENTINA 348 10.6.2.1 Availability of highly trained specialists and low cost of medical services boosting medical tourism industry 348 10.6.3 REST OF SOUTH AMERICA 356 11 COMPETITIVE LANDSCAPE 365 11.1 OVERVIEW 365 11.2 KEY PLAYER STRATEGIES 365 11.3 REVENUE ANALYSIS, 2022–2024 368 11.4 MARKET SHARE ANALYSIS, 2024 368 11.5 COMPANY VALUATION AND FINANCIAL METRICS 371 11.6 BRAND/PRODUCT COMPARISON ANALYSIS 372 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 373 11.7.1 STARS 373 11.7.2 EMERGING LEADERS 373 11.7.3 PERVASIVE PLAYERS 373 11.7.4 PARTICIPANTS 373 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 375 11.7.5.1 Company footprint 375 11.7.5.2 Region footprint 376 11.7.5.3 Type footprint 377 11.7.5.4 Application footprint 378 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 379 11.8.1 PROGRESSIVE COMPANIES 379 11.8.2 RESPONSIVE COMPANIES 379 11.8.3 DYNAMIC COMPANIES 379 11.8.4 STARTING BLOCKS 379 11.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024 381 11.8.5.1 Detailed list of key startups/SMEs 381 11.8.5.2 Competitive benchmarking of key startups/SMEs 382 11.9 COMPETITIVE SCENARIO 383 11.9.1 PRODUCT LAUNCHES 383 11.9.2 DEALS 384 11.9.3 EXPANSIONS 386 12 COMPANY PROFILES 390 12.1 MAJOR PLAYERS 390 12.1.1 BASF 390 12.1.1.1 Business overview 390 12.1.1.2 Products/Services/Solutions offered 391 12.1.1.3 Recent developments 392 12.1.1.3.1 Product launches 392 12.1.1.3.2 Deals 393 12.1.1.4 MnM view 393 12.1.1.4.1 Key strengths 393 12.1.1.4.2 Strategic choices 393 12.1.1.4.3 Weaknesses and competitive threats 394 12.1.2 SABIC 395 12.1.2.1 Business overview 395 12.1.2.2 Products/Services/Solutions offered 396 12.1.2.3 Recent developments 397 12.1.2.3.1 Deals 397 12.1.2.4 MnM view 398 12.1.2.4.1 Key strengths 398 12.1.2.4.2 Strategic choices 398 12.1.2.4.3 Weaknesses and competitive threats 398 12.1.3 COVESTRO AG 399 12.1.3.1 Business overview 399 12.1.3.2 Products/Services/Solutions offered 400 12.1.3.3 Recent developments 401 12.1.3.3.1 Product launches 401 12.1.3.3.2 Expansions 401 12.1.3.4 MnM view 402 12.1.3.4.1 Key strengths 402 12.1.3.4.2 Strategic choices 403 12.1.3.4.3 Weaknesses and competitive threats 403 12.1.4 CELANESE CORPORATION 404 12.1.4.1 Business overview 404 12.1.4.2 Products/Services/Solutions offered 405 12.1.4.3 Recent developments 406 12.1.4.3.1 Deals 406 12.1.4.3.2 Expansions 407 12.1.4.4 MnM view 407 12.1.4.4.1 Key strengths 407 12.1.4.4.2 Strategic choices 408 12.1.4.4.3 Weaknesses and competitive threats 408 12.1.5 EVONIK INDUSTRIES 409 12.1.5.1 Business overview 409 12.1.5.2 Products/Services/Solutions offered 410 12.1.5.3 Recent developments 411 12.1.5.3.1 Product launches 411 12.1.5.3.2 Expansions 412 12.1.5.4 MnM view 413 12.1.5.4.1 Key strengths 413 12.1.5.4.2 Strategic choices 413 12.1.5.4.3 Weaknesses and competitive threats 413 12.1.6 ARKEMA 414 12.1.6.1 Business overview 414 12.1.6.2 Products/Services/Solutions offered 415 12.1.6.3 Recent developments 416 12.1.6.3.1 Product launches 416 12.1.6.3.2 Deals 416 12.1.6.3.3 Expansions 417 12.1.6.4 MnM view 417 12.1.6.4.1 Key strengths 417 12.1.7 SOLVAY 419 12.1.7.1 Business overview 419 12.1.7.2 Products/Services/Solutions offered 421 12.1.7.3 MnM view 421 12.1.7.3.1 Key strengths 421 12.1.8 KURARAY CO., LTD. 422 12.1.8.1 Business overview 422 12.1.8.2 Products/Services/Solutions offered 423 12.1.8.3 Recent developments 424 12.1.8.3.1 Expansions 424 12.1.8.4 MnM view 424 12.1.9 MOMENTIVE PERFORMANCE MATERIALS INC. 425 12.1.9.1 Business overview 425 12.1.9.2 Products/Services/Solutions offered 425 12.1.9.3 Recent developments 426 12.1.9.3.1 Deals 426 12.1.9.3.2 Expansions 426 12.1.9.4 MnM view 427 12.1.10 DUPONT 428 12.1.10.1 Business overview 428 12.1.10.2 Products/Services/Solutions offered 429 12.1.10.3 Recent developments 429 12.1.10.3.1 Deals 429 12.1.10.3.2 Expansions 429 12.1.10.4 MnM view 430 12.2 OTHER PLAYERS 431 12.2.1 TRINSEO 431 12.2.2 KRATON CORPORATION 432 12.2.3 TOTAL PLASTICS 433 12.2.4 SIMONA AMERICA 434 12.2.5 DSM 435 12.2.6 INVIBIO 436 12.2.7 AVIENT CORPORATION 436 12.2.8 RTP COMPANY 437 12.2.9 TEKNIPLEX 438 12.2.10 TEKNOR APEX 439 12.2.11 MITSUBISHI CHEMICALS ADVANCED MATERIALS 440 12.2.12 WACKER CHIMIE 440 12.2.13 HARDIE POLYMERS 441 12.2.14 ELIX POLYMERS 442 12.2.15 INNOVATIVE POLYMER COMPOUNDS 443 13 APPENDIX 444 13.1 DISCUSSION GUIDE 444 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 447 13.3 CUSTOMIZATION OPTIONS 449 13.4 RELATED REPORTS 449 13.5 AUTHOR DETAILS 450
圖表清單 List of Tables & Figures
TABLE 1 MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS 29 TABLE 2 MEDICAL POLYMER MARKET: PORTER’S FIVE FORCES ANALYSIS 55 TABLE 3 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018–2025 59 TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS 61 TABLE 5 KEY BUYING CRITERIA IN MAJOR APPLICATIONS 62 TABLE 6 MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM 65 TABLE 7 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68 TABLE 11 MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2025−2026 74 TABLE 12 AVERAGE SELLING PRICE OF MEDICAL POLYMER, BY REGION, 2022–2024 (USD/KG) 75 TABLE 13 AVERAGE SELLING PRICE OF MEDICAL POLYMER OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 (USD/KG) 77 TABLE 14 TOP 10 PATENT OWNERS, 2015–2024 82 TABLE 15 TABLE 1: US-ADJUSTED RECIPROCAL TARIFF RATES 83 TABLE 16 MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 88 TABLE 17 MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 89 TABLE 18 MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 90 TABLE 19 MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 91 TABLE 20 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 99 TABLE 21 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 100 TABLE 22 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 100 TABLE 23 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 100 TABLE 24 MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 105 TABLE 25 MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 106 TABLE 26 MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 107 TABLE 27 MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 108 TABLE 28 MEDICAL POLYMER MARKET, BY REGION, 2022–2024 (USD MILLION) 118 TABLE 29 MEDICAL POLYMER MARKET, BY REGION, 2025–2030 (USD MILLION) 119 TABLE 30 MEDICAL POLYMER MARKET, BY REGION, 2022–2024 (KILOTON) 119 TABLE 31 MEDICAL POLYMER MARKET, BY REGION, 2025–2030 (KILOTON) 119 TABLE 32 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 121 TABLE 33 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 121 TABLE 34 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON) 121 TABLE 35 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON) 121 TABLE 36 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 122 TABLE 37 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 123 TABLE 38 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 124 TABLE 39 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 125 TABLE 40 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 126 TABLE 41 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 127 TABLE 42 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 128 TABLE 43 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 129 TABLE 44 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 129 TABLE 45 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 130 TABLE 46 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 130 TABLE 47 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 130 TABLE 48 US: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 132 TABLE 49 US: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 133 TABLE 50 US: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 134 TABLE 51 US: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 135 TABLE 52 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 136 TABLE 53 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 137 TABLE 54 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 138 TABLE 55 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 139 TABLE 56 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 141 TABLE 57 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 142 TABLE 58 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 143 TABLE 59 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 144 TABLE 60 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 145 TABLE 61 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 146 TABLE 62 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 147 TABLE 63 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 148 TABLE 64 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 149 TABLE 65 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 150 TABLE 66 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 151 TABLE 67 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 152 TABLE 68 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 153 TABLE 69 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 154 TABLE 70 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 155 TABLE 71 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 156 TABLE 72 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 157 TABLE 73 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 158 TABLE 74 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON) 158 TABLE 75 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON) 158 TABLE 76 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 159 TABLE 77 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 160 TABLE 78 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 161 TABLE 79 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 162 TABLE 80 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 163 TABLE 81 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 164 TABLE 82 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 165 TABLE 83 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 166 TABLE 84 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 166 TABLE 85 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 167 TABLE 86 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 167 TABLE 87 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 167 TABLE 88 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 169 TABLE 89 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 170 TABLE 90 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 171 TABLE 91 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 172 TABLE 92 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 173 TABLE 93 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 174 TABLE 94 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 175 TABLE 95 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 176 TABLE 96 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 177 TABLE 97 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 178 TABLE 98 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 179 TABLE 99 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 180 TABLE 100 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 181 TABLE 101 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 182 TABLE 102 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 183 TABLE 103 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 184 TABLE 104 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 186 TABLE 105 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 187 TABLE 106 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 188 TABLE 107 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 189 TABLE 108 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 190 TABLE 109 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 191 TABLE 110 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 192 TABLE 111 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 193 TABLE 112 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 194 TABLE 113 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 195 TABLE 114 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 196 TABLE 115 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 197 TABLE 116 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 198 TABLE 117 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 199 TABLE 118 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 200 TABLE 119 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 201 TABLE 120 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 202 TABLE 121 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 203 TABLE 122 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 204 TABLE 123 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 205 TABLE 124 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 206 TABLE 125 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 207 TABLE 126 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 208 TABLE 127 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 209 TABLE 128 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 210 TABLE 129 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 211 TABLE 130 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 212 TABLE 131 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 213 TABLE 132 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 214 TABLE 133 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 215 TABLE 134 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 216 TABLE 135 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 217 TABLE 136 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 218 TABLE 137 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 218 TABLE 138 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON) 219 TABLE 139 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON) 219 TABLE 140 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 220 TABLE 141 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 221 TABLE 142 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 222 TABLE 143 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 223 TABLE 144 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 224 TABLE 145 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 225 TABLE 146 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 226 TABLE 147 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 227 TABLE 148 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 227 TABLE 149 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 228 TABLE 150 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 228 TABLE 151 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 228 TABLE 152 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 230 TABLE 153 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 231 TABLE 154 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 232 TABLE 155 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 233 TABLE 156 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 234 TABLE 157 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 235 TABLE 158 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 236 TABLE 159 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 237 TABLE 160 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 238 TABLE 161 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 239 TABLE 162 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 240 TABLE 163 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 241 TABLE 164 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 242 TABLE 165 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 243 TABLE 166 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 244 TABLE 167 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 245 TABLE 168 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 246 TABLE 169 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 247 TABLE 170 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 248 TABLE 171 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 249 TABLE 172 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 250 TABLE 173 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 251 TABLE 174 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 252 TABLE 175 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 253 TABLE 176 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 254 TABLE 177 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 255 TABLE 178 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 256 TABLE 179 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 257 TABLE 180 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 258 TABLE 181 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 259 TABLE 182 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 260 TABLE 183 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 261 TABLE 184 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 262 TABLE 185 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 263 TABLE 186 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 264 TABLE 187 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 265 TABLE 188 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 266 TABLE 189 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 267 TABLE 190 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 268 TABLE 191 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 269 TABLE 192 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 271 TABLE 193 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 271 TABLE 194 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON) 271 TABLE 195 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON) 272 TABLE 196 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 272 TABLE 197 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 273 TABLE 198 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 274 TABLE 199 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 275 TABLE 200 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 276 TABLE 201 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 277 TABLE 202 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 278 TABLE 203 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 279 TABLE 204 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 279 TABLE 205 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 280 TABLE 206 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 280 TABLE 207 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 280 TABLE 208 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 282 TABLE 209 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 283 TABLE 210 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 284 TABLE 211 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 285 TABLE 212 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 286 TABLE 213 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 287 TABLE 214 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 288 TABLE 215 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 289 TABLE 216 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 290 TABLE 217 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 291 TABLE 218 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 292 TABLE 219 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 293 TABLE 220 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 294 TABLE 221 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 295 TABLE 222 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 296 TABLE 223 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 297 TABLE 224 UK: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 298 TABLE 225 UK: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 299 TABLE 226 UK: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 300 TABLE 227 UK: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 301 TABLE 228 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 302 TABLE 229 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 303 TABLE 230 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 304 TABLE 231 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 305 TABLE 232 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 306 TABLE 233 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 307 TABLE 234 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 308 TABLE 235 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 309 TABLE 236 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 310 TABLE 237 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 311 TABLE 238 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 312 TABLE 239 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 313 TABLE 240 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 314 TABLE 241 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 315 TABLE 242 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 316 TABLE 243 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 317 TABLE 244 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 318 TABLE 245 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 319 TABLE 246 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 320 TABLE 247 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 321 TABLE 248 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 322 TABLE 249 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 323 TABLE 250 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 324 TABLE 251 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 325 TABLE 252 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 326 TABLE 253 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 327 TABLE 254 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 328 TABLE 255 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 329 TABLE 256 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 330 TABLE 257 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 330 TABLE 258 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON) 330 TABLE 259 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON) 330 TABLE 260 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 331 TABLE 261 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 332 TABLE 262 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 333 TABLE 263 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 334 TABLE 264 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 335 TABLE 265 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 336 TABLE 266 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 337 TABLE 267 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 338 TABLE 268 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 338 TABLE 269 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 339 TABLE 270 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 339 TABLE 271 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 339 TABLE 272 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 341 TABLE 273 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 342 TABLE 274 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 343 TABLE 275 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 344 TABLE 276 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 345 TABLE 277 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 346 TABLE 278 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 347 TABLE 279 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 348 TABLE 280 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 349 TABLE 281 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 350 TABLE 282 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 351 TABLE 283 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 352 TABLE 284 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 353 TABLE 285 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 354 TABLE 286 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 355 TABLE 287 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 356 TABLE 288 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 357 TABLE 289 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 358 TABLE 290 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 359 TABLE 291 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 360 TABLE 292 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 361 TABLE 293 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 362 TABLE 294 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 363 TABLE 295 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 364 TABLE 296 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2025 365 TABLE 297 MEDICAL POLYMER MARKET: DEGREE OF COMPETITION 369 TABLE 298 MEDICAL POLYMER MARKET: REGION FOOTPRINT 376 TABLE 299 MEDICAL POLYMER MARKET: TYPE FOOTPRINT 377 TABLE 300 MEDICAL POLYMER MARKET: APPLICATION FOOTPRINT 378 TABLE 301 MEDICAL POLYMER MARKET: KEY STARTUPS/SMES 381 TABLE 302 MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 382 TABLE 303 MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 383 TABLE 304 MEDICAL POLYMER MARKET: DEALS, JANUARY 2021–JULY 2025 384 TABLE 305 MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021–JULY 2025 386 TABLE 306 BASF: COMPANY OVERVIEW 390 TABLE 307 BASF: PRODUCTS/SERVICES/SOLUTIONS OFFERED 391 TABLE 308 BASF: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 392 TABLE 309 BASF: DEALS, JANUARY 2021–JULY 2025 393 TABLE 310 SABIC: COMPANY OVERVIEW 395 TABLE 311 SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 396 TABLE 312 SABIC: DEALS, JANUARY 2021–JULY 2025 397 TABLE 313 COVESTRO AG: COMPANY OVERVIEW 399 TABLE 314 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 400 TABLE 315 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 401 TABLE 316 COVESTRO AG: EXPANSIONS, JANUARY 2021–JULY 2025 401 TABLE 317 CELANESE CORPORATION: COMPANY OVERVIEW 404 TABLE 318 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 405 TABLE 319 CELANESE CORPORATION: DEALS, JANUARY 2021–JULY 2025 406 TABLE 320 CELANESE CORPORATION: EXPANSIONS, JANUARY 2021–JULY 2025 407 TABLE 321 EVONIK INDUSTRIES: COMPANY OVERVIEW 409 TABLE 322 EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 410 TABLE 323 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 411 TABLE 324 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021–JULY 2025 412 TABLE 325 ARKEMA: COMPANY OVERVIEW 414 TABLE 326 ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 415 TABLE 327 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 416 TABLE 328 ARKEMA: DEALS, JANUARY 2021–JULY 2025 416 TABLE 329 ARKEMA: EXPANSIONS, JANUARY 2021–JULY 2025 417 TABLE 330 SOLVAY: COMPANY OVERVIEW 419 TABLE 331 SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 421 TABLE 332 KURARAY CO., LTD.: COMPANY OVERVIEW 422 TABLE 333 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 423 TABLE 334 KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021–JULY 2025 424 TABLE 335 MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW 425 TABLE 336 MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 425 TABLE 337 MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021–JULY 2025 426 TABLE 338 MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS, JANUARY 2021–JULY 2025 426 TABLE 339 DUPONT: COMPANY OVERVIEW 428 TABLE 340 DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 429 TABLE 341 DUPONT: DEALS, JANUARY 2021–JULY 2025 429 TABLE 342 DUPONT: EXPANSIONS, JANUARY 2021–JULY 2025 429 TABLE 343 TRINSEO: COMPANY OVERVIEW 431 TABLE 344 KRATON CORPORATION: COMPANY OVERVIEW 432 TABLE 345 TOTAL PLASTICS: COMPANY OVERVIEW 433 TABLE 346 SIMONA AMERICA: COMPANY OVERVIEW 434 TABLE 347 DSM: COMPANY OVERVIEW 435 TABLE 348 INVIBIO: COMPANY OVERVIEW 436 TABLE 349 AVIENT CORPORATION: COMPANY OVERVIEW 436 TABLE 350 RTP COMPANY: COMPANY OVERVIEW 437 TABLE 351 TEKNIPLEX: COMPANY OVERVIEW 438 TABLE 352 TEKNOR APEX: COMPANY OVERVIEW 439 TABLE 353 MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW 440 TABLE 354 WACKER CHIMIE: COMPANY OVERVIEW 440 TABLE 355 HARDIE POLYMERS: COMPANY OVERVIEW 441 TABLE 356 ELIX POLYMERS: COMPANY OVERVIEW 442 TABLE 357 INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW 443 FIGURE 1 MEDICAL POLYMER MARKET SEGMENTATION AND REGIONAL SCOPE 28 FIGURE 2 MEDICAL POLYMER MARKET: RESEARCH DESIGN 31 FIGURE 3 MEDICAL POLYMER MARKET: BOTTOM-UP APPROACH 35 FIGURE 4 MEDICAL POLYMER MARKET: TOP-DOWN APPROACH 36 FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL POLYMER MARKET TOP-DOWN APPROACH 36 FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS 37 FIGURE 7 MEDICAL POLYMER MARKET: DATA TRIANGULATION 38 FIGURE 8 MEDICAL PLASTICS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 42 FIGURE 9 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD 43 FIGURE 10 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 43 FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 44 FIGURE 12 INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD 45 FIGURE 13 MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD 45 FIGURE 14 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 46 FIGURE 15 EXTRUSION TUBING SEGMENT TO HOLD LARGEST SHARE DURING FORECAST PERIOD 46 FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 47 FIGURE 17 MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48 FIGURE 18 PORTER’S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET 56 FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS 60 FIGURE 20 KEY BUYING CRITERIA IN MAJOR APPLICATIONS 61 FIGURE 21 MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS 63 FIGURE 22 MEDICAL POLYMER ECOSYSTEM 64 FIGURE 23 MEDICAL POLYMER MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 71 FIGURE 24 IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020–2024 (USD MILLION) 72 FIGURE 25 EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020–2024 (USD MILLION) 73 FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 75 FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022–2024 76 FIGURE 28 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 77 FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2019−2023 (USD MILLION) 78 FIGURE 32 LEGAL STATUS OF PATENTS, 2015–2024 80 FIGURE 35 MEDICAL PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 87 FIGURE 36 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 99 FIGURE 37 MEDICAL INSTRUMENTS & DEVICES TO HOLD LARGEST SHARE DURING FORECAST PERIOD 104 FIGURE 38 MEDICAL POLYMER MARKET SNAPSHOT 118 FIGURE 39 NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT 120 FIGURE 40 ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT 157 FIGURE 41 EUROPE: MEDICAL POLYMER MARKET SNAPSHOT 270 FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2022–2024 368 FIGURE 43 SHARES OF TOP FIVE COMPANIES IN MEDICAL POLYMER MARKET, 2024 369 FIGURE 44 VALUATION OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024 371 FIGURE 45 FINANCIAL METRICS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024 372 FIGURE 46 MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON 372 FIGURE 47 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 374 FIGURE 48 MEDICAL POLYMER MARKET: COMPANY FOOTPRINT 375 FIGURE 49 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 380 FIGURE 50 BASF: COMPANY SNAPSHOT 391 FIGURE 51 SABIC: COMPANY SNAPSHOT 396 FIGURE 52 COVESTRO AG: COMPANY SNAPSHOT 400 FIGURE 53 CELANESE CORPORATION: COMPANY SNAPSHOT 405 FIGURE 54 EVONIK INDUSTRIES: COMPANY SNAPSHOT 410 FIGURE 55 ARKEMA: COMPANY SNAPSHOT 415 FIGURE 56 SOLVAY: COMPANY SNAPSHOT 420 FIGURE 57 KURARAY CO., LTD.: COMPANY SNAPSHOT 423 FIGURE 58 DUPONT: COMPANY SNAPSHOT 428

同分類最新報告（化學與材料）

查看化學與材料全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們